The goal of this activity is for learners to be better able to recognize the key differences in gene therapies for hemophilia A compared with hemophilia B, and to leverage evolving data about gene therapies for hemophilia to better care for patients.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/clinical-assessment-gene-therapies-hemophilia-and-hemophilia-2024a1000orm
- Start Date: 2024-12-26 06:00:00
- End Date: 2024-12-26 06:00:00
- Credit Details: AAPA Category 1 Credit™️: 1.25 hours
AMA PRA Category 1 Credit™️: 1.25 hours
Pharmacy: 1.25 hours - MOC Credit Details: ABIM - 1.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: CSL Behring, LLC - Amount: 77661.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Hematology
Subscribe
Login
0 Comments
Oldest